Thus, the high percentage of SAβ-gal positive cancer cells within our HER2+ breast cancer samples might suggest that oncogenic HER2-induced senescence results in a secretome that can inhibit the recruitment of immune cells and thereby reduced elimination of the senescent cells, leading to accumulation of senescent cells within these tumors. Here, ERBB2 is linked to breast cancer.